Cargando…
ODP118 PTH (1-34) Replacement Therapy for Hypoparathyroidism due to Sporadic Calcium Sensing Receptor Gain-of-Function Point Mutation
BACKGROUND: The calcium sensing receptor (CASR) regulates parathyroid hormone secretion in response to extracellular calcium concentration. A gain-of-function mutation of the CASR lowers the set point for extracellular calcium sensing, resulting in both reduced parathyroid hormone secretion and incr...
Autores principales: | Basina, Marina, Bhalla, Vivek, Shah, Nandi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9624846/ http://dx.doi.org/10.1210/jendso/bvac150.360 |
Ejemplares similares
-
ODP100 Hypoparathyroidism in the Setting of COVID-19: Increasingly Common Phenomenon
por: Markov, Alexander, et al.
Publicado: (2022) -
ODP104 Isolated familial hypoparathyroidism with Tbx1 mutation in Korea
por: Lee, Seunghyun, et al.
Publicado: (2022) -
SAT-396 A Non-Surgical Animal Model of Hypoparathyroidism for Testing PTH Analogues
por: Ramezani-Pour, Narjes, et al.
Publicado: (2020) -
PSAT158 Dimeric [Cys25]PTH(1-34) and Monomeric PTH(1-34) Differentially Regulate the Expression of Genes Related to Calcium Homeostasis in Bone and Kidney
por: Lee, Sihoon, et al.
Publicado: (2022) -
Serum Calcium Levels in Adult Patients With Chronic Hypoparathyroidism Treated With rhPTH(1–84) Compared With a Historical Control Cohort
por: Rejnmark, Lars, et al.
Publicado: (2021)